660 related articles for article (PubMed ID: 30067922)
21. Differential diagnosis of polyuric/polydipsic syndromes with the aid of urinary vasopressin measurement in adults.
Diederich S; Eckmanns T; Exner P; Al-Saadi N; Bähr V; Oelkers W
Clin Endocrinol (Oxf); 2001 May; 54(5):665-71. PubMed ID: 11380498
[TBL] [Abstract][Full Text] [Related]
22. Changes in plasma copeptin, the c-terminal portion of arginine vasopressin during water deprivation and excess in healthy subjects.
Szinnai G; Morgenthaler NG; Berneis K; Struck J; Müller B; Keller U; Christ-Crain M
J Clin Endocrinol Metab; 2007 Oct; 92(10):3973-8. PubMed ID: 17635944
[TBL] [Abstract][Full Text] [Related]
23. The diagnostic role of arginine-stimulated copeptin in the differential diagnosis of polyuria-polydipsia syndrome (PPS) in pediatric age.
Tuli G; Munarin J; De Sanctis L
Endocrine; 2024 May; 84(2):677-682. PubMed ID: 38155322
[TBL] [Abstract][Full Text] [Related]
24. Plasmatic arginine vasopressin levels in total and partial diabetes insipidus.
Sanmartí A; Galard R; Catalàn R; Foz M; Castellanos JM
J Endocrinol Invest; 1985 Apr; 8(2):127-30. PubMed ID: 4031379
[TBL] [Abstract][Full Text] [Related]
25. Plasma Apelin Concentrations in Patients With Polyuria-Polydipsia Syndrome.
Urwyler SA; Timper K; Fenske W; de Mota N; Blanchard A; Kühn F; Frech N; Arici B; Rutishauser J; Kopp P; Stettler C; Müller B; Katan M; Llorens-Cortes C; Christ-Crain M
J Clin Endocrinol Metab; 2016 May; 101(5):1917-23. PubMed ID: 26967692
[TBL] [Abstract][Full Text] [Related]
26. Diabetes insipidus.
Christ-Crain M; Gaisl O
Presse Med; 2021 Dec; 50(4):104093. PubMed ID: 34718110
[TBL] [Abstract][Full Text] [Related]
27. The use of arginine vasopressin measurements in the polyuric dog.
Biewenga WJ; van den Brom WE; Mol JA
Tijdschr Diergeneeskd; 1987 Apr; 112 Suppl 1():117S-120S. PubMed ID: 3576593
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic value of the water deprivation test in the polyuria-polydipsia syndrome.
Trimpou P; Olsson DS; Ehn O; Ragnarsson O
Hormones (Athens); 2017 Oct; 16(4):414-422. PubMed ID: 29518762
[TBL] [Abstract][Full Text] [Related]
29. Diabetes Insipidus: An Update.
Refardt J; Winzeler B; Christ-Crain M
Endocrinol Metab Clin North Am; 2020 Sep; 49(3):517-531. PubMed ID: 32741486
[TBL] [Abstract][Full Text] [Related]
30. Diagnosis and management of diabetes insipidus for the internist: an update.
Christ-Crain M; Winzeler B; Refardt J
J Intern Med; 2021 Jul; 290(1):73-87. PubMed ID: 33713498
[TBL] [Abstract][Full Text] [Related]
31. The usefulness of copeptin for the diagnosis of nephrogenic diabetes insipidus in infancy: a case report.
Bitencourt L; Fischer BL; de Oliveira Campos JL; Vaz de Castro PAS; Soares de Brito SBC; Versiani CM; Soares BS; Drummond JB; Simões E Silva AC
J Pediatr Endocrinol Metab; 2021 Nov; 34(11):1475-1479. PubMed ID: 34291622
[TBL] [Abstract][Full Text] [Related]
32. Use of copeptin in interpretation of the water deprivation test.
Rowe M; Patel N; Jeffery J; Flanagan D
Endocrinol Diabetes Metab; 2023 May; 6(3):e399. PubMed ID: 37002645
[TBL] [Abstract][Full Text] [Related]
33. Simplified and improved fluid deprivation test for diagnosing diabetes insipidus.
Sjöström A; Bartuseviciene I; Höybye C
Eur J Endocrinol; 2021 Jan; 184(1):123-131. PubMed ID: 33112270
[TBL] [Abstract][Full Text] [Related]
34. The water deprivation test and a potential role for the arginine vasopressin precursor copeptin to differentiate diabetes insipidus from primary polydipsia.
de Fost M; Oussaada SM; Endert E; Linthorst GE; Serlie MJ; Soeters MR; DeVries JH; Bisschop PH; Fliers E
Endocr Connect; 2015 Jun; 4(2):86-91. PubMed ID: 25712898
[TBL] [Abstract][Full Text] [Related]
35. Glucagon-stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: a double-blind, randomized, placebo-controlled study.
Atila C; Gaisl O; Vogt DR; Werlen L; Szinnai G; Christ-Crain M
Eur J Endocrinol; 2022 May; 187(1):65-74. PubMed ID: 35521789
[TBL] [Abstract][Full Text] [Related]
36. Copeptin is increased by nausea and vomiting during hypertonic saline infusion in healthy individuals.
Brooks E; Bachmeier C; Vorster J; Sorbello J; Peer F; Chikani V; Dimeski G; Ungerer J; Pretorius C; Inder W
Clin Endocrinol (Oxf); 2021 May; 94(5):820-826. PubMed ID: 33445207
[TBL] [Abstract][Full Text] [Related]
37. [Copeptin is a new diagnostic biomarker for diabetes insipidus].
Stankovic J; Rittig S; Jørgensen JOL; Søndergaard E
Ugeskr Laeger; 2020 Dec; 182(51):. PubMed ID: 33317692
[TBL] [Abstract][Full Text] [Related]
38. [New Diagnostic Standard in Diabetes Insipidus].
Chifu I; Fenske W
Dtsch Med Wochenschr; 2018 Dec; 143(24):1739-1744. PubMed ID: 30508851
[TBL] [Abstract][Full Text] [Related]
39. Copeptin assays in children for the differential diagnosis of polyuria-polydipsia syndrome and reference levels in hospitalized children.
Bonnet L; Marquant E; Fromonot J; Hamouda I; Berbis J; Godefroy A; Vierge M; Tsimaratos M; Reynaud R
Clin Endocrinol (Oxf); 2022 Jan; 96(1):47-53. PubMed ID: 34694022
[TBL] [Abstract][Full Text] [Related]
40. New insights on diagnosis and treatment of AVP deficiency.
Refardt J; Atila C; Christ-Crain M
Rev Endocr Metab Disord; 2024 Jun; 25(3):639-649. PubMed ID: 38087160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
